DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹500 Cr | ₹611 Cr | ₹557 Cr | ₹437 Cr | ₹364 Cr |
What is the latest Total Non-Current Liabilities ratio of DIVIS LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹500 Cr |
| Mar2024 | ₹611 Cr |
| Mar2023 | ₹557 Cr |
| Mar2022 | ₹437 Cr |
| Mar2021 | ₹364 Cr |
How is Total Non-Current Liabilities of DIVIS LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹500 Cr | -18.17 | |
| Mar2024 | ₹611 Cr | 9.69 | |
| Mar2023 | ₹557 Cr | 27.60 | |
| Mar2022 | ₹437 Cr | 19.94 | |
| Mar2021 | ₹364 Cr | - | |
Compare Total Non-Current Liabilities of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹167,124.3 Cr | 1.8% | 4.8% | 6.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,613.0 Cr | 0.9% | 6.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,926.0 Cr | 1.3% | 9.8% | 37.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,088.0 Cr | 1.7% | 5.8% | 6.7% | Stock Analytics | |
| CIPLA | ₹107,120.0 Cr | -1.3% | 0.9% | -8.9% | Stock Analytics | |
| MANKIND PHARMA | ₹84,468.2 Cr | -0.9% | -2.7% | -13.6% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 1.8% |
4.8% |
6.3% |
| SENSEX | 0% |
1.2% |
9.7% |
You may also like the below Video Courses